-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Scopus BioPharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q2 2023.
- Scopus BioPharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$2.62M, a 21.2% increase year-over-year.
- Scopus BioPharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$8.7M, a 45.3% increase year-over-year.
- Scopus BioPharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$11.6M, a 56.9% increase from 2021.
- Scopus BioPharma Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$27M, a 148% decline from 2020.
- Scopus BioPharma Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$10.9M, a 304% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)